Advisor Partners’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Advisor Partners's IDXX Position: Q2 2022 in Review
Advisor Partners increased its Idexx Laboratories (IDXX) stake by 9.4% in Q2 2022, buying an estimated $101K and bringing the position to 2,882 shares worth $1.01M. The position accounts for 0.07% of the portfolio, ranked #286.
Advisor Partners first reported a position in IDXX in Q3 2016 and has held it in 24 quarters since. The position peaked at $1.49M in Q4 2021. 957 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.
- Advisor Partners held 2,882 shares of Idexx Laboratories worth $1.01M as of Q2 2022.
- Advisor Partners bought 248 Idexx Laboratories shares in Q2 2022, an estimated $101K.
- Idexx Laboratories made up 0.07% of Advisor Partners's portfolio in Q2 2022, its #286 holding.
- Advisor Partners first reported a position in Idexx Laboratories in Q3 2016 and has held it in 24 quarters since.
- Advisor Partners's Idexx Laboratories position peaked at $1.49M in Q4 2021.
- 957 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.
Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.